Assessing a sustainable manufacturing route to lapatinib

Show simple item record

dc.contributor.author Stark, Roderick T.
dc.contributor.author Pye, Dominic R.
dc.contributor.author Chen, Wenyi
dc.contributor.author Newton, Oliver J.
dc.contributor.author Deadman, Benjamin J.
dc.contributor.author Miller, Philip W.
dc.contributor.author Panayides, Jenny-Lee
dc.contributor.author Riley, Darren Lyall
dc.contributor.author Hellgardt, Klaus
dc.contributor.author Hii, King Kuok (Mimi)
dc.date.accessioned 2023-10-16T07:37:26Z
dc.date.available 2023-10-16T07:37:26Z
dc.date.issued 2022-10
dc.description.abstract A synthetic route to an anti-cancer drug, lapatinib, was devised to support the development of a sustainable manufacturing process in South Africa. Quantitative metrics were employed to evaluate the sustainability of the key steps of the reaction. en_US
dc.description.department Chemistry en_US
dc.description.librarian am2023 en_US
dc.description.sponsorship The ROAR facility by EPSRC. en_US
dc.description.uri https://pubs.rsc.org/en/journals/journalissues/re en_US
dc.identifier.citation Stark, R.T., Pye, D.R., Chen, W. et al. 2022, 'Assessing a sustainable manufacturing route to lapatinib', Reaction Chemistry and Engineering, vol. 7, no. 11, pp. 2420-2426, doi : 10.1039/d2re00267a. en_US
dc.identifier.issn 2058-9883 (online)
dc.identifier.other 10.1039/d2re00267a
dc.identifier.uri http://hdl.handle.net/2263/92873
dc.language.iso en en_US
dc.publisher Royal Society of Chemistry en_US
dc.rights © The Royal Society of Chemistry 2022. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. en_US
dc.subject Anti-cancer drug en_US
dc.subject Lapatinib en_US
dc.subject Quantitative metrics en_US
dc.subject SDG-03: Good health and well-being en_US
dc.subject South Africa (SA) en_US
dc.title Assessing a sustainable manufacturing route to lapatinib en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record